CompuGroup Medical SE & Co. KGaA

    CompuGroup Medical SE & Co. KGaA

    XXETR:COP
    - -
    EUR
    - -
    - -
    43.29P/E
    CompuGroup Medical SE & Co. KGaA
    XETR:COP
    (Deutsche Borse Xetra)

    Recent

    price

    - -

    P/E

    ratio

    43.29

    div

    yld

    - -

    ROIC.AI

    2009
    2010
    2011
    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    2023
    2024
    TTM
    EUR
    5.95
    6.22
    7.95
    9.06
    9.24
    10.36
    10.92
    11.27
    11.71
    14.57
    15.41
    15.58
    19.59
    21.63
    22.74
    22.31
    22.35
    Revenue per Share
    0.23
    0.33
    0.19
    0.62
    0.47
    0.52
    0.77
    0.9
    0.63
    1.95
    1.36
    1.36
    1.32
    1.41
    0.88
    0.67
    0.52
    Basic EPS, GAAP
    0.49
    0.42
    0.48
    1.35
    0.57
    0.64
    1.47
    1.36
    1.73
    2.77
    2.28
    2.79
    3.16
    2.78
    3.44
    2.49
    2.78
    Free Cash Flow per Basic Share
    - -
    0.25
    0.25
    0.25
    0.35
    0.35
    0.35
    0.35
    0.35
    0.35
    0.5
    0.45
    0.5
    0.5
    0.5
    1
    1
    Dividend per Share
    1.05
    1.06
    1.06
    1.07
    1.07
    1.07
    1.07
    1.07
    1.07
    1.08
    1.1
    1
    1.03
    1.03
    1.03
    1.04
    1.04
    Book Value per Share
    -2.49
    -3.94
    -5.81
    -5.56
    -6.1
    -6.88
    -7.07
    -6.43
    -6.26
    -5.54
    -8.44
    -8.36
    -11.5
    -11.87
    -12.26
    -13.67
    -13.35
    Tangible Book Value per Share
    50
    50
    50
    50
    50
    50
    50
    50
    50
    49
    48
    54
    52
    52
    52
    52
    52
    Basic Weighted Avg Shares
    300
    312
    397
    451
    460
    515
    543
    560
    582
    717
    746
    837
    1,025
    1,130
    1,188
    1,154
    1,156
    Sales/Revenue/Turnover
    8.26
    10.63
    9.03
    14.55
    11.98
    8.37
    12.23
    14.05
    15.81
    20.2
    15.95
    14.97
    10.52
    9.51
    10.35
    9.16
    8.68
    Operating Margin (%)
    34
    34
    36
    41
    41
    43
    45
    44
    38
    45
    63
    76
    111
    112
    116
    112
    112
    Depreciation Expense
    12
    17
    10
    31
    23
    26
    38
    45
    31
    96
    66
    73
    69
    73
    46
    35
    27
    Net Income, GAAP
    36.04
    36.72
    62.02
    37.11
    37.02
    45.92
    37.91
    40.08
    51.58
    28.16
    38.6
    33.51
    29.47
    30.61
    35.5
    43.84
    46.66
    Effective Tax Rate (%)
    3.9
    5.37
    2.43
    6.82
    5.04
    5.05
    7.09
    7.95
    5.37
    13.4
    8.83
    8.74
    6.73
    6.5
    3.87
    3
    2.34
    Profit Margin (%)
    -26
    -9
    -46
    -66
    -31
    2
    -29
    -10
    -16
    9
    -3
    18
    -28
    45
    23
    63
    50
    Working Capital
    109
    191
    238
    225
    278
    344
    326
    328
    318
    320
    453
    498
    626
    733
    741
    826
    795
    LT Debt
    186
    183
    168
    179
    183
    176
    193
    219
    223
    264
    260
    639
    612
    674
    669
    648
    652
    Total Equity
    4.87
    5.62
    3.11
    8.72
    6.94
    4.32
    7.04
    7.64
    7.47
    17.59
    10.45
    8.34
    5.89
    5.21
    5.29
    3.85
    3.56
    Return on Invested Capital (%)
    9.1
    9.98
    4.62
    12.25
    9.47
    9.23
    10.68
    11.67
    8.24
    25.32
    14.51
    13.16
    10.36
    9.66
    7.29
    6.06
    5.21
    Return on Capital (%)
    22.01
    31.55
    18.11
    57.72
    43.49
    48.86
    72.33
    83.67
    58.72
    180.55
    123.68
    136.87
    128.35
    136.62
    85.45
    64.39
    50.24
    Return on Common Equity (%)

    Capital Structure

    EUR

    •

    in mil. unless spec.
    Sep'24
    Dec'24
    Mar'25
    ST Debt
    75
    54
    31
    LT Borrowings
    743
    794
    765
    LT Finance Leases
    33
    32
    31
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    52
    52
    52
    Market Capitalization
    738
    1,129
    1,169

    Working Capital

    EUR

    •

    in mil. unless spec.
    Sep'24
    Dec'24
    Mar'25
    Total Current Assets
    378
    395
    462
    Cash, Cash Equivalents & STI
    80
    108
    129
    Accounts Receivable, Net
    170
    167
    208
    Inventories
    19
    15
    15
    Total Current Liabilities
    366
    331
    412
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    75
    54
    31
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    EUR

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    18.99%
    29.58%
    -3.13%
    Free Cash Flow
    21.77%
    5.85%
    -28.21%
    Net Income, GAAP
    15.96%
    -10.05%
    -24.65%
    Sales/Revenue/Turnover
    8.69%
    9.44%
    -2.84%
    Total Cash Common Dividend
    - -
    - -
    98.09%

    Quarterly Revenue

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    291
    304
    286
    307
    1,188
    2024
    285
    277
    283
    309
    1,154
    2025
    286
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    0.28
    0.6
    0.31
    - -
    0.88
    2024
    0.35
    0.27
    0.17
    - -
    0.67
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    0.5
    - -
    - -
    0.5
    2024
    - -
    1
    - -
    - -
    1
    2025
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business